Increased dopaminergic inhibition of prolactin in the hypoprolactinaemic IPL nude rat.
In this study, aimed at investigating whether dopaminergic regulation of prolactin could be implicated in the hypoprolactinaemia observed in the IPL nude rat, dopaminergic inhibition of prolactin was suppressed using a catecholamine synthesis inhibitor alpha-methyltyrosine (MT) and a dopaminergic antagonist sulpiride. Adult male rats (IPL nude and normal) were injected through implanted atrial cannulae with either MT (250 mg/kg) or physiological saline (control). Rats were decapitated 2 h after the injection. Plasma prolactin levels, compared with basal values, increased by 15.6 +/- 1.9 (S.E.M.)- and 5.89 +/- 0.6-fold in IPL nude and normal rats respectively. This difference was highly significant. The pituitary prolactin content was decreased in both groups. In a second experiment, adult male IPL nude or normal rats were injected with either sulpiride (1 mg/kg) or saline and decapitated 2, 4, 8, 12, 14 and 24 h later. Plasma prolactin levels, compared with basal values, were increased in rats injected with sulpiride by 9.2 +/- 1.8 and 3.4 +/- 0.7-fold in IPL nude and normal rats respectively. The pituitary prolactin content was reduced more in IPL nude than in normal sulpiride-injected rats. These data suggest that prolactin secretion, as well as synthesis, is under an increased dopaminergic inhibition in the male IPL nude rat.
D000818:Animals; D004298:Dopamine / Q000502:physiology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D010902:Pituitary Gland / Q000378:metabolism; D011388:Prolactin / Q000097:blood* / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011922:Rats, Mutant Strains; D013469:Sulpiride / Q000494:pharmacology
D008781:Methyltyrosines; C022260:alpha-methyltyrosine methyl ester; D013469:Sulpiride; D011388:Prolactin; D004298:Dopamine